General Velabs Therapeutics Announces €3 Million Series B Financing to Advance its Functional Antibody Screening Programme 28/06/2019 Annabelle Grimm
General EMBL spin-off Velabs Therapeutics to cooperate with Chiome Bioscience in the field of GPCR-specific functional antibody screening 24/04/2019 Annabelle Grimm
